The firm said in a statement on Tuesday that the India-based pharma major Morepen Laboratories has started to manufacture test batches for the Russo-made Sputnik V anti-coronavirus V vaccine in India in an endeavour to improve its production capacity in the nation.
Morepen and RDIF, Russia’s worldwide marketing sovereign investment fund have announced their manufacturing of vaccination test lot in an unique Himachal Pradesh State facility.
On 12 April 2021, following the indigenous development of Covaxin and Covishield, sputnik V was the third vaccine to receive an emergency usage permit for India.
Discussion about this post